Engimmune Therapeutics’ Post

What does the future of cancer treatment look like in 2034? 🔮 As we observe 🎗️ World Cancer Day today, we take a look at the different kinds of treatments and ongoing research that are poised to make a difference ten years down the line. 📅 From immunotherapy to precision medicine to cancer vaccines 💉, there is hope that cancer care will change for the better, although making the process for receiving treatment more affordable needs to be addressed. 💵 Labiotech spoke to experts like John Maher, CSO of Leucid Bio, Germo Gericke, CMO of Ariceum Therapeutics, Catherine Pickering, CEO of iOnctura, Lars Nieba, CEO of Engimmune Therapeutics, Liam Tremble, Principal Scientist at Poolbeg Pharma plc, and Jason Loveridge, CEO of 4SC AG, to find out more about what the future of cancer care holds in store. Read our latest article to find out! 👇 https://lnkd.in/deaSPBAB #cancerresearch #futureofcancertreatment #worldcancerday #immunotherapyadvancements #precisionmedicine #cancervaccines #affordabletreatment #medicalinnovation #expertinsights